Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Zheng-Ran Chuai"'
Autor:
Dong Chen, Jun-Fu Huang, Kai Liu, Li-Qun Zhang, Zhao Yang, Zheng-Ran Chuai, Yun-Xia Wang, Da-Chuan Shi, Qing Huang, Wei-Ling Fu
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90607 (2014)
BACKGROUND: Colorectal cancer (CRC) is a heterogeneous disease with multiple underlying causative genetic mutations. The B-type Raf proto-oncogene (BRAF) plays an important role in the mitogen-activated protein kinase (MAPK) signaling cascade during
Externí odkaz:
https://doaj.org/article/c34b62c2d2954f9eb137bda523e9b79e
Autor:
Dong Chen, Zhao Yang, Han Xia, Jun-Fu Huang, Yang Zhang, Tian-Nun Jiang, Gui-Yu Wang, Zheng-Ran Chuai, Wei-Ling Fu, Qing Huang
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e91824 (2014)
Genotyping of thiopurine S-methyltransferase (TPMT) is recommended for predicting the adverse drug response of thiopurines. In the current study, a novel version of allele-specific PCR (AS-PCR), termed competitive real-time fluorescent AS-PCR (CRAS-P
Externí odkaz:
https://doaj.org/article/e79cb035336b43cfbb5ed79642eb7b5e
Autor:
Dong Chen, Li-Qun Zhang, Jun-Fu Huang, Kai Liu, Zheng-Ran Chuai, Zhao Yang, Yun-Xia Wang, Da-Chuan Shi, Qian Liu, Qing Huang, Wei-Ling Fu
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e101354 (2014)
BRAF mutations have been well described in non-small cell lung cancer (NSCLC) for several years, but the clinical features of patients harboring BRAF mutations are still not well described. We performed a meta-analysis to identify common clinical fea
Externí odkaz:
https://doaj.org/article/363686d0f6f540d7ba30e81ee197f875
Autor:
Qing Huang, Xiaoyan Zhu, Jia Peng, Zheng-Ran Chuai, Dong Chen, Da-Chuan Shi, Hai-Yan Wu, Huan Wang, Weiling Fu, Jun-Fu Huang
Publikováno v:
Biosensors and Bioelectronics. 62:280-287
Rolling circle amplification (RCA) of DNA is a sensitive and cost effective method for the rapid identification of pathogens without the need for sequencing. In this study, a surface plasmon resonance DNA biosensor based on RCA with a gold (Au) nanop
Autor:
Dong Chen, Guang-Jie Duan, Zheng-Ran Chuai, Han Xia, Qing Huang, Zhao Yang, Jun-Fu Huang, Weiling Fu
Publikováno v:
Analytical and Bioanalytical Chemistry. 406:2477-2487
The response to epidermal growth factor receptor (EGFR)-targeted therapy in metastatic colorectal cancer (mCRC) is variable because of intra-tumor heterogeneity at the genetic level, and consequently, it is important to develop sensitive and selectiv
Autor:
Weiling Fu, Han Xia, Dong Chen, Tian-Nun Jiang, Gui-Yu Wang, Jun-Fu Huang, Qing Huang, Zhao Yang, Zheng-Ran Chuai, Yang Zhang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 4, p e91824 (2014)
PLoS ONE, Vol 9, Iss 4, p e91824 (2014)
Genotyping of thiopurine S-methyltransferase (TPMT) is recommended for predicting the adverse drug response of thiopurines. In the current study, a novel version of allele-specific PCR (AS-PCR), termed competitive real-time fluorescent AS-PCR (CRAS-P
Autor:
Kai Liu, Weiling Fu, Qian Liu, Zheng-Ran Chuai, Yan-Yan Wang, Jun-Fu Huang, Zhao Yang, Liqun Zhang, Qing Huang, Yunxia Wang, Dong Chen, Da-Chuan Shi
Publikováno v:
Scientific Reports
The high-resolution melting curve analysis (HRMA) might be a good alternative method for rapid detection of BRAF mutations. However, the accuracy of HRMA in detection of BRAF mutations has not been systematically evaluated. We performed a systematic
Autor:
Kai Liu, Weiling Fu, Qing Huang, Liqun Zhang, Yunxia Wang, Jun-Fu Huang, Zheng-Ran Chuai, Zhao Yang, Da-Chuan Shi, Dong Chen
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90607 (2014)
PLoS ONE
PLoS ONE
Background Colorectal cancer (CRC) is a heterogeneous disease with multiple underlying causative genetic mutations. The B-type Raf proto-oncogene (BRAF) plays an important role in the mitogen-activated protein kinase (MAPK) signaling cascade during C
Autor:
Weiling Fu, Jun-Fu Huang, Qing Huang, Zheng-Ran Chuai, Liqun Zhang, Kai Liu, Dong Chen, Da-Chuan Shi, Yunxia Wang, Zhao Yang, Qian Liu
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e101354 (2014)
PLoS ONE
PLoS ONE
Background BRAF mutations have been well described in non-small cell lung cancer (NSCLC) for several years, but the clinical features of patients harboring BRAF mutations are still not well described. We performed a meta-analysis to identify common c
Autor:
Dong Chen, Yan-Yan Wang, Zheng-Ran Chuai, Jun-Fu Huang, Yun-Xia Wang, Kai Liu, Li-Qun Zhang, Zhao Yang, Da-Chuan Shi, Qian Liu, Qing Huang, Wei-Ling Fu
Publikováno v:
Scientific Reports; 2/28/2014, p1-7, 7p